{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:45:48Z","timestamp":1791805548157,"version":"4.3.4"},"reference-count":27,"publisher":"Walter de Gruyter GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_cclm-2026-1238_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Long COVID is defined by persistent multi-organ symptoms without an alternative diagnosis. This study evaluated whether routine laboratory data collected under real-world conditions differentiate symptom-defined subgroups within an outpatient cohort and predict the course.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_cclm-2026-1238_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this single-center cohort study of 564 Long COVID patients (1,452 visits), symptom phenotypes were derived by latent class analysis of 19\u00a0organ-system domains at baseline. Structure in 89 routine analytes was sought by k-means clustering, confirmed with alternative algorithms, and repeated after age residualization. Analytes were compared across phenotypes using Kruskal-Wallis tests with false-discovery-rate control and adjustment for confounders. Equivalence testing was performed against reference change values. The course was modeled by count models. Prediction of improvement used a nested cross-validated elastic net with a baseline-independent endpoint.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_cclm-2026-1238_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Clustering showed no convincing structure (silhouette\u00a0\u22640.09, two to eight clusters); the weak split tracked age (50.5 vs. 38\u00a0years) and vanished after residualization. Three age-independent phenotypes (n=503) had no laboratory correlate: none of 89 analytes survived FDR correction, with or without adjustment, or across 50\u00a0pseudo-class draws. Equivalence held for 86\/89 analytes within \u00b10.5 SD and 63\/70 within the reference change value. Symptom burden declined (median 4 to 2 organ systems, p=2.5\u00a0\u00d7\u00a010\n                      <jats:sup>\u221219<\/jats:sup>\n                      ); however, no analyte predicted the course (AUC\u00a00.46).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_cclm-2026-1238_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Routine laboratory variation in this cohort was dominated by age and decoupled from symptom phenotype in both directions. Routine testing in a real-world setting could not provide an age-independent diagnostic, subtyping, or prognostic signature in a cohort of patients suffering from Long COVID.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/cclm-2026-1238","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T10:55:50Z","timestamp":1791802550000},"source":"Crossref","is-referenced-by-count":0,"title":["Routine laboratory data are decoupled from symptom phenotype and prognosis in Long COVID: within-cohort variation is dominated by age"],"prefix":"10.1515","author":[{"given":"Viola","family":"Oberhauser","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine , Medical University of Vienna , Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Perkmann","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine , Medical University of Vienna , Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Mucher","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine , Medical University of Vienna , Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Quehenberger","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine , Medical University of Vienna , Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Fritzer-Szekeres","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine , Medical University of Vienna , Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Szekeres","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine , Medical University of Vienna , Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrig","family":"Marculescu-Ferrari","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine , Medical University of Vienna , Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ena","family":"Hasimbegovic","sequence":"additional","affiliation":[{"name":"Department of Medicine II , Division of Cardiology, Medical University of Vienna , Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Domanig","sequence":"additional","affiliation":[{"name":"Department of Medicine II , Division of Cardiology, Medical University of Vienna , Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Hamzaraj","sequence":"additional","affiliation":[{"name":"Department of Medicine II , Division of Cardiology, Medical University of Vienna , Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Poschenreithner","sequence":"additional","affiliation":[{"name":"Department of Medicine II , Division of Cardiology, Medical University of Vienna , Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisbona","family":"Kastrati","sequence":"additional","affiliation":[{"name":"Department of Medicine II , Division of Cardiology, Medical University of Vienna , Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika","family":"Lukovic","sequence":"additional","affiliation":[{"name":"Department of Medicine II , Division of Cardiology, Medical University of Vienna , Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine and Cell Therapy , Medical University of Vienna , Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"Bergler-Klein","sequence":"additional","affiliation":[{"name":"Department of Medicine II , Division of Cardiology, Medical University of Vienna , Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oswald F.","family":"Wagner","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine , Medical University of Vienna , Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariann","family":"Gy\u00f6ngy\u00f6si","sequence":"additional","affiliation":[{"name":"Department of Medicine II , Division of Cardiology, Medical University of Vienna , Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4605-2503","authenticated-orcid":false,"given":"Helmuth","family":"Haslacher","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine , Medical University of Vienna , Vienna , Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"key":"2026101210554372457_j_cclm-2026-1238_ref_001","doi-asserted-by":"crossref","unstructured":"Soriano, JB, Murthy, S, Marshall, JC, Relan, P, Diaz, JV. WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 2022;22:e102\u20137. https:\/\/doi.org\/10.1016\/s1473-3099(21)00703-9.","DOI":"10.1016\/S1473-3099(21)00703-9"},{"key":"2026101210554372457_j_cclm-2026-1238_ref_002","doi-asserted-by":"crossref","unstructured":"Lippi, G, Henry, BM, Favresse, J, Plebani, M. Addressing standardized definitions of post-COVID and long-COVID. Clin Chem Lab Med 2023;61:1361\u20132. https:\/\/doi.org\/10.1515\/cclm-2023-0390.","DOI":"10.1515\/cclm-2023-0390"},{"key":"2026101210554372457_j_cclm-2026-1238_ref_003","doi-asserted-by":"crossref","unstructured":"Davis, HE, McCorkell, L, Vogel, JM, Topol, EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 2023;21:133\u201346. https:\/\/doi.org\/10.1038\/s41579-022-00846-2.","DOI":"10.1038\/s41579-022-00846-2"},{"key":"2026101210554372457_j_cclm-2026-1238_ref_004","doi-asserted-by":"crossref","unstructured":"Parotto, M, Gyongyosi, M, Howe, K, Myatra, SN, Ranzani, O, Shankar-Hari, M, et al.. Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations. Lancet Respir Med 2023;11:739\u201354. https:\/\/doi.org\/10.1016\/s2213-2600(23)00239-4.","DOI":"10.1016\/S2213-2600(23)00239-4"},{"key":"2026101210554372457_j_cclm-2026-1238_ref_005","doi-asserted-by":"crossref","unstructured":"Erlandson, KM, Geng, LN, Selvaggi, CA, Thaweethai, T, Chen, P, Erdmann, NB, et al.. Differentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort. Ann Intern Med 2024;177:1209\u201321. https:\/\/doi.org\/10.7326\/m24-0737.","DOI":"10.7326\/M24-0737"},{"key":"2026101210554372457_j_cclm-2026-1238_ref_006","doi-asserted-by":"crossref","unstructured":"Peter, RS, Nieters, A, Gopel, S, Merle, U, Steinacker, JM, Deibert, P, et al.. Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19\/post-COVID-19 syndrome in the second year after acute infection: a population-based, nested case-control study. PLoS Med 2025;22:e1004511. https:\/\/doi.org\/10.1371\/journal.pmed.1004511.","DOI":"10.1371\/journal.pmed.1004511"},{"key":"2026101210554372457_j_cclm-2026-1238_ref_007","doi-asserted-by":"crossref","unstructured":"Collins, E, Philippe, E, Gravel, CA, Hawken, S, Langlois, MA, Little, J. Serological markers and long COVID-a rapid systematic review. Eur J Clin Invest 2024;54:e14149. https:\/\/doi.org\/10.1111\/eci.14149.","DOI":"10.1111\/eci.14149"},{"key":"2026101210554372457_j_cclm-2026-1238_ref_008","doi-asserted-by":"crossref","unstructured":"Klein, J, Wood, J, Jaycox, JR, Dhodapkar, RM, Lu, P, Gehlhausen, JR, et al.. Distinguishing features of long COVID identified through immune profiling. Nature 2023;623:139\u201348. https:\/\/doi.org\/10.1038\/s41586-023-06651-y.","DOI":"10.1038\/s41586-023-06651-y"},{"key":"2026101210554372457_j_cclm-2026-1238_ref_009","doi-asserted-by":"crossref","unstructured":"Thaweethai, T, Jolley, SE, Karlson, EW, Levitan, EB, Levy, B, McComsey, GA, et al.. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA 2023;329:1934\u201346. https:\/\/doi.org\/10.1001\/jama.2023.8823.","DOI":"10.1001\/jama.2023.15712"},{"key":"2026101210554372457_j_cclm-2026-1238_ref_010","doi-asserted-by":"crossref","unstructured":"Hu, M, Song, T, Gong, Z, Che, Q, Guo, J, Chen, L, et al.. Symptom Trajectories and Clinical Subtypes in Post-COVID-19 Condition: Systematic Review and Clustering Analysis. JMIR Public Health Surveill 2025;11:e72221. https:\/\/doi.org\/10.2196\/72221.","DOI":"10.2196\/72221"},{"key":"2026101210554372457_j_cclm-2026-1238_ref_011","doi-asserted-by":"crossref","unstructured":"Haslam, A, Olivier, T, Prasad, V. The definition of long COVID used in interventional studies. Eur J Clin Invest 2023;53:e13989. https:\/\/doi.org\/10.1111\/eci.13989.","DOI":"10.1111\/eci.13989"},{"key":"2026101210554372457_j_cclm-2026-1238_ref_012","doi-asserted-by":"crossref","unstructured":"Humkamp, K, Costa, AS, Reetz, K, Walders, J. Post-COVID-19\u00a0condition-clinical phenotyping in practice. Nervenarzt 2024;95:1091\u2013103.","DOI":"10.1007\/s00115-024-01753-y"},{"key":"2026101210554372457_j_cclm-2026-1238_ref_013","doi-asserted-by":"crossref","unstructured":"Mfouth Kemajou, P, Besse-Hammer, T, Lebouc, C, Coppieters, Y. Cluster analysis identifies long COVID subtypes in Belgian patients. Biol Methods Protoc 2024;9:bpae076. https:\/\/doi.org\/10.1093\/biomethods\/bpae076.","DOI":"10.1093\/biomethods\/bpae076"},{"key":"2026101210554372457_j_cclm-2026-1238_ref_014","doi-asserted-by":"crossref","unstructured":"Reese, JT, Blau, H, Casiraghi, E, Bergquist, T, Loomba, JJ, Callahan, TJ, et al.. Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes. EBioMedicine 2023;87:104413. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104413.","DOI":"10.1016\/j.ebiom.2022.104413"},{"key":"2026101210554372457_j_cclm-2026-1238_ref_015","doi-asserted-by":"crossref","unstructured":"Carobene, A, Milella, F, Famiglini, L, Cabitza, F. How is test laboratory data used and characterised by machine learning models? A systematic review of diagnostic and prognostic models developed for COVID-19 patients using only laboratory data. Clin Chem Lab Med 2022;60:1887\u2013901. https:\/\/doi.org\/10.1515\/cclm-2022-0182.","DOI":"10.1515\/cclm-2022-0182"},{"key":"2026101210554372457_j_cclm-2026-1238_ref_016","doi-asserted-by":"crossref","unstructured":"Gyongyosi, M, Hasimbegovic, E, Han, E, Zlabinger, K, Spannbauer, A, Riesenhuber, M, et al.. Improvement of Symptoms and Cardiac Magnetic Resonance Abnormalities in Patients with Post-Acute Sequelae of SARS-CoV-2 Cardiovascular Syndrome (PASC-CVS) After Guideline-Oriented Therapy. Biomedicines 2023;11:3312. https:\/\/doi.org\/10.3390\/biomedicines11123312.","DOI":"10.3390\/biomedicines11123312"},{"key":"2026101210554372457_j_cclm-2026-1238_ref_017","doi-asserted-by":"crossref","unstructured":"Gyongyosi, M, Lukovic, D, Mester-Tonczar, J, Zlabinger, K, Einzinger, P, Spannbauer, A, et al.. Effect of monovalent COVID-19 vaccines on viral interference between SARS-CoV-2 and several DNA viruses in patients with long-COVID syndrome. NPJ Vaccines 2023;8:145. https:\/\/doi.org\/10.1038\/s41541-023-00739-2.","DOI":"10.1038\/s41541-023-00739-2"},{"key":"2026101210554372457_j_cclm-2026-1238_ref_018","doi-asserted-by":"crossref","unstructured":"Kovarik, JJ, Bileck, A, Hagn, G, Meier-Menches, SM, Frey, T, Kaempf, A, et al.. A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndrome. iScience 2023;26:105717. https:\/\/doi.org\/10.1016\/j.isci.2022.105717.","DOI":"10.1016\/j.isci.2022.105717"},{"key":"2026101210554372457_j_cclm-2026-1238_ref_019","doi-asserted-by":"crossref","unstructured":"Hamzaraj, K, Han, E, Hasimbegovic, E, Poschenreiter, L, Vavrikova, A, Lukovic, D, et al.. Impact of Circulating Anti-Spike Protein Antibody Levels on Multi-Organ Long COVID Symptoms. Vaccines (Basel) 2024;12:610. https:\/\/doi.org\/10.3390\/vaccines12060610.","DOI":"10.3390\/vaccines12060610"},{"key":"2026101210554372457_j_cclm-2026-1238_ref_020","doi-asserted-by":"crossref","unstructured":"von Elm, E, Altman, DG, Egger, M, Pocock, SJ, Gotzsche, PC, Vandenbroucke, JP, et al.. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J\u00a0Clin Epidemiol 2008;61:344\u20139. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008.","DOI":"10.1016\/j.jclinepi.2007.11.008"},{"key":"2026101210554372457_j_cclm-2026-1238_ref_021","doi-asserted-by":"crossref","unstructured":"Prasannan, N, Heightman, M, Hillman, T, Wall, E, Bell, R, Kessler, A, et al.. Impaired exercise capacity in post-COVID-19 syndrome: the role of VWF-ADAMTS13 axis. Blood Adv 2022;6:4041\u20138. https:\/\/doi.org\/10.1182\/bloodadvances.2021006944.","DOI":"10.1182\/bloodadvances.2021006944"},{"key":"2026101210554372457_j_cclm-2026-1238_ref_022","doi-asserted-by":"crossref","unstructured":"Oner, P, Yilmaz, S, Dogan, S. High Homocysteine Levels are Associated with Cognitive Impairment in Patients who Recovered from COVID-19 in the Long Term. J\u00a0Pers Med 2023;13:503. https:\/\/doi.org\/10.3390\/jpm13030503.","DOI":"10.3390\/jpm13030503"},{"key":"2026101210554372457_j_cclm-2026-1238_ref_023","doi-asserted-by":"crossref","unstructured":"Krcmova, LK, Javorska, L, Matousova, K, Smahel, P, Skala, M, Kopecky, M, et al.. Evaluation of inflammatory biomarkers and vitamins in hospitalized patients with SARS-CoV-2 infection and post-COVID syndrome. Clin Chem Lab Med 2024;62:1217\u201327. https:\/\/doi.org\/10.1515\/cclm-2023-1297.","DOI":"10.1515\/cclm-2023-1297"},{"key":"2026101210554372457_j_cclm-2026-1238_ref_024","doi-asserted-by":"crossref","unstructured":"Evans, RA, McAuley, H, Harrison, EM, Shikotra, A, Singapuri, A, Sereno, M, et al.. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med 2021;9:1275\u201387. https:\/\/doi.org\/10.1016\/s2213-2600(21)00383-0.","DOI":"10.1016\/S2213-2600(21)00383-0"},{"key":"2026101210554372457_j_cclm-2026-1238_ref_025","doi-asserted-by":"crossref","unstructured":"PHOSP-COVID Collaborative Group. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med 2022;10:761\u201375.","DOI":"10.1016\/S2213-2600(22)00127-8"},{"key":"2026101210554372457_j_cclm-2026-1238_ref_026","doi-asserted-by":"crossref","unstructured":"Kedor, C, Freitag, H, Meyer-Arndt, L, Wittke, K, Hanitsch, LG, Zoller, T, et al.. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat Commun 2022;13:5104. https:\/\/doi.org\/10.1038\/s41467-022-32507-6.","DOI":"10.1038\/s41467-022-32507-6"},{"key":"2026101210554372457_j_cclm-2026-1238_ref_027","doi-asserted-by":"crossref","unstructured":"Lugtu, EJ, Pilapil, DY4th, Cabunoc, MH, Bautista, JL, Pleta, FM, Ng, JA, et al.. Prevalence of post-COVID symptoms across variants of concern and follow-up periods: a systematic review and meta-analysis. Int J Infect Dis 2026;166:108522. https:\/\/doi.org\/10.1016\/j.ijid.2026.108522.","DOI":"10.1016\/j.ijid.2026.108522"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2026-1238\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2026-1238\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T10:55:59Z","timestamp":1791802559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2026-1238\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":27,"alternative-id":["10.1515\/cclm-2026-1238"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2026-1238","relation":{},"ISSN":["1434-6621","1437-4331"],"issn-type":[{"value":"1434-6621","type":"print"},{"value":"1437-4331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,13]]}}}